ArticleInflammatory bowel diseases2021

Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.

Ruben J Colman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.